Cloned (Comment) | Organism |
---|---|
expression of wild-type and mutant enzymes in Escherichia coli strain Rosetta 2 (DE3)pLysS | Leishmania mexicana |
Crystallization (Comment) | Organism |
---|---|
enzyme complexed with inhibitor 4-[(1,1-dioxo-1,2-benzothiazol-3-yl)sulfanyl]benzoic acid, mxing of 0.0015 ml of 10 mg/ml protein in 20 mM TEA, pH 7.2, 1 mM 1,3,6,8-pyrenetetrasulfonic acid, and 9 mM inhibitor, with 0.0015 ml of well solution containing 12-16% PEG 8000, 20 mM TEA buffer, pH 7.2, 50 mM magnesium chloride, 100 mM potassium chloride, and 10% glycerol, 1-2 days, and equilibration for 14 h over a well solution composed of 14-18% PEG 8,000, 20 mM TEA buffer, pH 7.2, 50 mM magnesium chloride, 100 mM potassium chloride, and 25% glycerol, X-ray diffraction structure determination and analysis at 2.65 A resolution | Leishmania mexicana |
Protein Variants | Comment | Organism |
---|---|---|
K335R | site-directed mutagenesis, structure compared to the wild-type, overview | Leishmania mexicana |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-(2,5-dimethylphenoxy)-1,2-benzothiazole 1,1-dioxide | a saccharin derivative, potent inhibitor, but a labile compound | Leishmania mexicana | |
3-[(2,5-dimethylphenyl)sulfanyl]-1,2-benzothiazole 1,1-dioxide | a stable sulfur derivative of 3-(2,5-dimethylphenoxy)-1,2-benzothiazole 1,1-dioxide | Leishmania mexicana | |
4-[(1,1-dioxo-1,2-benzothiazol-3-yl)sulfanyl]benzoic acid | irreversible inhibitor, a saccharin derivative, reacts with an active-site lysine residue (Lys335), forming a covalent bond and sterically hindering the binding of ADP/ATP, covalent inhibitor mechanism, overview. Inhibition of LmPYK by the compound is time-dependent | Leishmania mexicana | |
additional information | the nitrogen analogue N-(2,5-dimethylphenyl)-1,2-benzothiazol-3-amine 1,1-dioxide of 3-(2,5-dimethylphenoxy)-1,2-benzothiazole 1,1-dioxide is not inhibitory | Leishmania mexicana |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Leishmania mexicana |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + pyruvate | Leishmania mexicana | - |
ADP + phosphoenolpyruvate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Leishmania mexicana | - |
- |
- |
Purification (Comment) | Organism |
---|---|
recombinant wild-type and mutant enzymes from Escherichia coli strain Rosetta 2 (DE3)pLysS | Leishmania mexicana |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + pyruvate | - |
Leishmania mexicana | ADP + phosphoenolpyruvate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PYK | - |
Leishmania mexicana |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Leishmania mexicana |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.2 | - |
assay at | Leishmania mexicana |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Leishmania mexicana |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.005 | - |
pH 7.2, 25°C | Leishmania mexicana | 3-[(2,5-dimethylphenyl)sulfanyl]-1,2-benzothiazole 1,1-dioxide | |
0.01 | - |
pH 7.2, 25°C | Leishmania mexicana | 3-(2,5-dimethylphenoxy)-1,2-benzothiazole 1,1-dioxide |
General Information | Comment | Organism |
---|---|---|
physiological function | PYK plays a central role in a number of proliferative and infectious diseases | Leishmania mexicana |